This content is from: Home

India’s Supreme Court dismisses Bayer’s linkage petition

The Supreme Court of India has dismissed an appeal filed by Bayer in a case that dealt with the question of whether the country’s IP office and its drug regulator should be linked

To access our in-house intelligence please request a trial here.

Read this article – and more – for a 30 day period.


Are you already an Managing IP subscriber? Login here


Instant access to all of our content. Membership Options | 30 Day Trial